Products & Services
Markets
Contact Us
Become a Partner
Blog
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Products & Services
Markets
Contact Us
Become a Partner
Blog
Reach out to us on
0120-4918900
Or
Get a call back
Click here
Markets
Company Info
Equity
IPO
Company Info
Derivatives
News
Announcements
Mutual Fund
Insurance
Share Price
Live Quotes
Company Profile
Board of Directors
Income Statement
Balance Sheet
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
Ratio Analysis
Cash Flow
Annual Results
Quarterly Results
Half Yearly Results
Shareholding
Change Name
MF Holding
Locations
Board Meetings
Corporate News
Investors Return
BOARD OF DIRECTORS
You can view Board of Directors of the company.
Bal Pharma Ltd.
GO
Jun 10
BSE
86.06
( -1.02 -1.17%)
Volume
2558
Prev. Close
87.08
Open Price
88.00
Today's Low / High
85.73
88.29
Bid. Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
59.69
112.97
Jun 10
NSE
86.15
( -1.64 -1.87%)
Volume
14282
Prev. Close
87.79
Open Price
87.00
Today's Low / High
86.11
89.46
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
60.00
111.18
ISIN No
INE083D01012
Market Cap. (
in Cr. )
137.16
P/BV
1.67
Book Value (
)
51.65
BSE Code
524824
52 Week High/Low (
)
111/60
FV/ML
10/1
P/E(X)
21.70
NSE Code
BALPHARMAEQ
Book Closure
25/09/2025
EPS (
)
3.97
Div Yield (%)
1.39
Date and Time
Headlines
29-May-2026 12:40PM
Bal Pharma - Non Applicability Of Statement Of Deviation & Variation
27-May-2026 7:06PM
Bal Pharma - Dividend
27-May-2026 7:01PM
Bal Pharma - Outcome of Board Meeting
27-May-2026 6:50PM
Bal Pharma - Outcome of Board Meeting
27-May-2026 6:43PM
Bal Pharma - Audited Financial Results-Standalone & Consolidated
27-May-2026 6:30PM
Bal Pharma - Board Meeting Outcome for Outcome Of The Board Meeting
27-May-2026 5:50PM
Bal Pharma Q4 net profit down 34.05% at Rs 3.70 cr
22-May-2026 5:52PM
Bal Pharma - Corrigendum
22-May-2026 5:37PM
Bal Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates
18-May-2026 3:13PM
Bal Pharma - Board Meeting Intimation for Intimation Of The Board Meeting